跳至主要内容
临床试验/NCT06313281
NCT06313281已完成不适用

Effectiveness of Preoperative Antiseptic Preparation in Transnasal Skull Base Surgery: A Randomized Three-Arm Controlled Trial

King Saud University2 个研究点 分布在 1 个国家目标入组 142 人开始时间: 2019年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
142
试验地点
2
主要终点
the difference in the incidence of postoperative infections within 30 days of surgery between the three interventional groups

研究概览

简要总结

Objective: Transnasal skull-base surgery is a complex and invasive procedure that involves the use of preoperative antiseptic preparations. However, evidence supporting their use in preventing postoperative infectious complications is limited. The aim of this study is to assess the efficacy of preoperative antiseptic techniques in reducing postoperative infectious complications within 30 days of surgery.

Methods: A multicenter, prospective, randomized, single-blind, three-arm trial was conducted from February 2019 to October 2021. Participants were randomized to either of three antiseptic preparation techniques: external 0.9%NaCl nasal preparation, external 0.05% chlorhexidine gluconate, or intranasal irrigation with 80 mg of gentamicin added to 1000 ml of 0.9%NaCl plus external nasal preparation with chlorhexidine gluconate 0.05%. A total of 130 adults with skull-base pathologies were randomized, 12 were excluded before randomization for failure to meet inclusion criteria (n=9) or refusal to participate (n=3). The investigators excluded patients with evidence of infection adjacent to the surgical site, allergies to preparation methods, those who underwent craniotomy during the same admission, and pediatric patients.

详细描述

Study Design This is a multicenter, prospective, randomized, single-blind, three-arm trial conducted at three skull base centers in Riyadh, Saudi Arabia. The null hypothesis was that infectious outcomes would not differ between the three intervention groups.

Ethics Consideration The patients provided written informed consent to participate, and the institutional review boards approved the study of the participating institutions. This study was approved by the Ethics Review Boards (E-18-3331). This study was conducted using the CONSORT guidelines.7

Population Patients were screened at neurosurgery service in three skull base centers from February 2019 to September 2021; follow-up was completed in October 2021. Eligible patients were adults with skull base pathologies scheduled for ETSBS. The exclusion criteria included pediatric patients aged <14 years, known allergy to CHG or gentamicin, evidence of infection at or adjacent to the operative site prior to surgery, open craniotomy during hospitalization, and immunosuppression. Fourteen years of age was used as the age limit as this is the age of the pediatric population in the Saudi health system.

Interventional Groups Three antiseptic preparation techniques were utilized in this study in a stepwise fashion, from minimal to maximal antisepsis: Group 1, external 0.9% NaCl nasal preparation; Group 2, external nasal preparation with antisepsis by CHG 0.05%; and Group 3, intranasal irrigation with 80 mg of gentamicin added to 1000 ml of 0.9% NaCl plus external nasal preparation with antisepsis by CHG 0.05%

Randomization Procedure Patients were randomized into blocks of three intervention groups and distributed to the participating centers. The primary surgeon was blinded to the intervention method until the day of surgery. The patients were randomized using a computer-generated list of random numbers (http://www.randomizer.org). Block randomization in three-patient blocks based on the institution was performed to ensure that approximately equal numbers of patients in each group from each site were randomized.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
14 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults with skull base pathologies scheduled for ETSBS

排除标准

  • Pediatric patients aged <14 years
  • Known allergy to CHG or gentamicin
  • Evidence of infection at or adjacent to the operative site prior to surgery
  • Open craniotomy during hospitalization
  • Immunosuppression

结局指标

主要结局

the difference in the incidence of postoperative infections within 30 days of surgery between the three interventional groups

时间窗: 30 days

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sarah Basindwah

Neurosurgery resident

King Saud University

研究点 (2)

Loading locations...

相似试验